Evidence map›Paper›PMID 19342601›Full record

ArticleCirculation research2009

Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.

Lucíola S Barcelos, Cécile Duplaa, Nicolle Kränkel, Gallia Graiani, Gloria Invernici, Rajesh Katare, Mauro Siragusa, Marco Meloni, Ilaria Campesi, Manuela Monica and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 248 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Isolation of endothelial progenitor cells from human adipose tissue.International journal of obesity (2005) · 2025
    Article
  5. Review
  6. Review
  7. X-Paste improves wound healing in diabetesWorld journal of diabetes · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Circulating endothelial precursor cells are associated with a healed diabetic foot ulcer evaluated in a prospective cohort study.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Local application reduces number of needed EPC for beneficial effects on wound healing compared to systemic treatment in mice.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2022
    Article
  18. Article
  19. Review
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Lucíola S BarcelosBristol Heart Institute, University of Bristol, Upper Maudlin Street, Bristol, United Kingdom.
Cécile Duplaa
Nicolle Kränkel
Gallia Graiani
Gloria Invernici
Rajesh Katare
Mauro Siragusa
Marco Meloni
Ilaria Campesi
Manuela Monica
Andreas Simm
Paola Campagnolo
Giuseppe Mangialardi
Lara Stevanato
Giulio Alessandri
Costanza Emanueli
Paolo Madeddu
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITMartin Luther University Halle-Wittenberg · DEIstituto Nazionale Biostrutture e Biosistemi · ITUniversity of Parma · IT

Funding

British Heart Foundation PG/06/035/20641British Heart Foundation PG/06/096/21325
6 · The paper itself

Abstract

We evaluated the healing potential of human fetal aorta-derived CD133(+) progenitor cells and their conditioned medium (CD133(+) CCM) in a new model of ischemic diabetic ulcer. Streptozotocin-induced diabetic mice underwent bilateral limb ischemia and wounding. One wound was covered with collagen containing 2x10(4) CD133(+) or CD133(-) cells or vehicle. The contralateral wound, covered with only collagen, served as control. Fetal CD133(+) cells expressed high levels of wingless (Wnt) genes, which were downregulated following differentiation into CD133(-) cells along with upregulation of Wnt antagonists secreted frizzled-related protein (sFRP)-1, -3, and -4. CD133(+) cells accelerated wound closure as compared with CD133(-) or vehicle and promoted angiogenesis through stimulation of endothelial cell proliferation, migration, and survival by paracrine effects. CD133(+) cells secreted high levels of vascular endothelial growth factor (VEGF)-A and interleukin (IL)-8. Consistently, CD133(+) CCM accelerated wound closure and reparative angiogenesis, with this action abrogated by co-administering the Wnt antagonist sFRP-1 or neutralizing antibodies against VEGF-A or IL-8. In vitro, these effects were recapitulated following exposure of high-glucose-primed human umbilical vein endothelial cells to CD133(+) CCM, resulting in stimulation of migration, angiogenesis-like network formation and induction of Wnt expression. The promigratory and proangiogenic effect of CD133(+) CCM was blunted by sFRP-1, as well as antibodies against VEGF-A or IL-8. CD133(+) cells stimulate wound healing by paracrine mechanisms that activate Wnt signaling pathway in recipients. These preclinical findings open new perspectives for the cure of diabetic ulcers.

Indexed as

Neovascularization, PhysiologicStem Cell TransplantationWound HealingAC133 AntigenAnimalsAntigens, CDAortaCell DifferentiationCell MovementCell ProliferationCells, CulturedCell SurvivalCulture Media, ConditionedDiabetes Mellitus, ExperimentalDiabetic FootFetal Stem CellsAC133 AntigenAntigens, CDCulture Media, ConditionedGlycoproteinsIntercellular Signaling Peptides and ProteinsInterleukin-8Membrane ProteinsPeptidesPROM1 protein, humanProm1 protein, mouseSecreted Frizzled-Related ProteinsSfrp1 protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseWnt Proteins

Identifiers

PMID19342601
PMCPMC2821014
OpenAlexW2145280222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.